Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 55, Issue 18, Pages 8193-8197Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm301115r
Keywords
-
Categories
Funding
- AIRC
- PRIN [2009PX2T2E]
- FIRB [RBFR10ZJQT]
- FP7 Project [BLUEPRINT/282510]
- Deutsche Forschungsgemeinschaft [Ju295/8-1]
- [PON01_01227]
Ask authors/readers for more resources
Inhibition of sirtuins has recently been proposed as a promising anticancer strategy. Some of the new benzodeazaoxaflavins (2a, 2b, and 2d) here reported as SIRT1/2 inhibitors were endowed with pro-apoptotic properties in human U937 leukemia cells and, most importantly, together with the prototype MC2141 (1) displayed antiproliferative effects in cancer stem cells from patients with colorectal carcinoma and glioblastoma multiforme, known to be highly tumorigenic, resistant to conventional cancer chemotherapy, and responsible, at least in part, for cancer relapse or recurrence.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available